Profile data is unavailable for this security.
About the company
Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. It has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
- Revenue in USD (TTM)7.65m
- Net income in USD-18.32m
- Incorporated2007
- Employees68.00
- LocationAvinger Inc400 Chesapeake DrREDWOOD CITY 94063-4739United StatesUSA
- Phone+1 (650) 363-2400
- Fax+1 (302) 655-5049
- Websitehttps://avinger.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Venus Concept Inc | 76.35m | -37.25m | 4.34m | 304.00 | -- | -- | -- | 0.0569 | -6.86 | -6.86 | 14.05 | -2.54 | 0.6972 | 1.03 | 2.30 | 251,164.50 | -33.83 | -32.71 | -50.39 | -44.01 | 68.32 | 68.16 | -48.52 | -48.50 | 1.39 | -3.93 | 1.22 | -- | -23.26 | 28.31 | 14.76 | -- | -35.08 | -- |
| Arch Therapeutics Inc | 115.33k | -7.86m | 4.39m | 8.00 | -- | -- | -- | 38.04 | -4.07 | -4.07 | 0.0509 | -2.02 | 0.0652 | 0.0613 | -- | 14,416.25 | -444.57 | -188.28 | -- | -804.63 | 27.04 | -- | -6,819.08 | -26,945.92 | 0.042 | -2.02 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
| Pressure Biosciences Inc | 2.27m | -29.56m | 4.80m | 15.00 | -- | -- | -- | 2.11 | -1.70 | -1.70 | 0.1299 | -1.22 | 1.02 | 2.28 | 9.17 | 151,505.30 | -1,074.63 | -643.54 | -- | -- | 6.89 | 34.75 | -1,050.30 | -798.21 | 0.0185 | -0.4182 | -- | -- | -13.64 | -5.05 | 21.52 | -- | -34.47 | -- |
| BIOLASE Inc | 49.16m | -37.62m | 4.83m | 157.00 | -- | -- | -- | 0.0982 | -37.97 | -37.97 | 38.54 | 0.5726 | 1.34 | 2.38 | 8.68 | 313,146.50 | -56.30 | -49.28 | -115.21 | -85.80 | 34.02 | 35.27 | -41.97 | -50.72 | 0.683 | -6.61 | 0.8778 | -- | 1.45 | 1.27 | -30.39 | -- | 18.63 | -- |
| ADM Tronics Unlimited Inc | 2.85m | -716.86k | 5.55m | 7.00 | -- | 5.03 | -- | 1.95 | -0.0106 | -0.0106 | 0.0421 | 0.0163 | 0.9772 | 3.85 | 4.25 | -- | -24.62 | -11.45 | -38.81 | -15.77 | 38.45 | 43.73 | -25.19 | -15.28 | 1.24 | -- | 0.2902 | -- | 14.66 | -0.4159 | 93.04 | -- | -- | -- |
| Guided Therapeutics Inc | 98.00k | -3.76m | 5.56m | 4.00 | -- | -- | -- | 56.75 | -0.074 | -0.074 | 0.0019 | -0.0703 | 0.0389 | 0.1051 | 15.08 | 24,500.00 | -138.59 | -136.13 | -- | -- | 36.73 | 29.39 | -3,560.20 | -3,666.67 | 0.1582 | -12.94 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
| Heart Test Laboratories Inc | 18.60k | -6.39m | 5.82m | 12.00 | -- | 0.6543 | -- | 313.00 | -0.4912 | -0.4912 | 0.0009 | 0.1357 | 0.0026 | 0.009 | 2.53 | 1,550.00 | -89.51 | -- | -120.71 | -- | 67.31 | -- | -34,362.42 | -- | 4.70 | -16.41 | 0.0547 | -- | -64.16 | -- | -31.61 | -- | -- | -- |
| Sigyn Therapeutics Inc | 0.00 | -4.15m | 6.43m | 5.00 | -- | -- | -- | -- | -3.82 | -3.82 | 0.00 | -2.65 | 0.00 | -- | -- | 0.00 | -1,266.54 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0189 | -1.20 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
| Avinger Inc | 7.65m | -18.32m | 6.64m | 68.00 | -- | -- | -- | 0.8676 | -26.38 | -26.38 | 9.74 | -4.85 | 0.4031 | 1.10 | 7.39 | 112,529.40 | -96.51 | -70.93 | -5,095.97 | -131.57 | 26.18 | 30.87 | -239.41 | -208.91 | 0.3557 | -9.68 | 1.77 | -- | -7.51 | -0.6736 | 32.76 | -- | -24.21 | -- |
| Fuse Medical Inc | 18.40m | 3.63m | 7.02m | 31.00 | 2.64 | -- | 1.90 | 0.3815 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
| Nu-Med Plus Inc | 0.00 | -125.53k | 7.10m | 2.00 | -- | -- | -- | -- | -0.0015 | -0.0015 | 0.00 | -0.0018 | 0.00 | -- | -- | 0.00 | -269.93 | -447.69 | -- | -- | -- | -- | -- | -- | -- | -24.11 | -- | -- | -- | -- | 3.56 | -- | -- | -- |
| Predictive Oncology Inc | 1.78m | -13.98m | 7.35m | 34.00 | -- | 0.8891 | -- | 4.13 | -3.48 | -3.48 | 0.4434 | 2.04 | 0.0887 | 1.37 | 5.35 | 52,355.88 | -69.66 | -91.80 | -86.54 | -126.29 | 64.34 | 64.64 | -785.57 | -1,419.99 | 2.43 | -- | 0.0179 | -- | 18.24 | 4.75 | 45.67 | -- | 5.44 | -- |
| Sonendo Inc | 43.87m | -60.92m | 7.39m | 216.00 | -- | 0.2346 | -- | 0.1685 | -0.6485 | -0.6485 | 0.4667 | 0.4472 | 0.4072 | 2.38 | 8.06 | 203,078.70 | -56.55 | -- | -74.56 | -- | 28.05 | -- | -138.88 | -- | 1.53 | -17.04 | 0.568 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
| Vivos Therapeutics Inc | 13.80m | -13.58m | 7.84m | 114.00 | -- | 11.74 | -- | 0.5683 | -11.08 | -11.08 | 11.49 | 0.2241 | 1.13 | -- | 41.88 | 121,061.40 | -111.11 | -89.72 | -262.52 | -149.70 | 59.93 | 70.20 | -98.42 | -113.15 | -- | -- | 0.00 | -- | -13.87 | 29.48 | 43.04 | -- | -8.48 | -- |
| Vapotherm Inc | 68.67m | -58.19m | 7.87m | 182.00 | -- | -- | -- | 0.1146 | -9.88 | -9.88 | 11.38 | -8.97 | 0.7902 | 1.44 | 6.95 | 377,302.20 | -66.96 | -49.73 | -86.11 | -62.54 | 41.27 | 43.56 | -84.74 | -78.99 | 1.23 | -1.98 | 2.07 | -- | 2.80 | 10.14 | 48.62 | -- | -10.38 | -- |
| Neurometrix Inc | 5.90m | -6.53m | 8.54m | 26.00 | -- | 0.3264 | -- | 1.45 | -6.29 | -6.29 | 5.67 | 13.18 | 0.2561 | 1.23 | 10.13 | 226,977.70 | -28.33 | -23.24 | -29.85 | -27.26 | 66.89 | 59.17 | -110.64 | -48.88 | 15.55 | -- | 0.00 | -- | -28.52 | -18.18 | -47.84 | -- | 5.03 | -- |
Data as of May 03 2024. Currency figures normalised to Avinger Inc's reporting currency: US Dollar USD
1.93%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 23.80k | 1.40% |
| BlackRock Fund Advisorsas of 31 Dec 2023 | 5.61k | 0.33% |
| Tower Research Capital LLCas of 31 Dec 2023 | 2.03k | 0.12% |
| UBS Securities LLCas of 31 Dec 2023 | 908.00 | 0.05% |
| City State Bank (Norwalk, Iowa) (Investment Management)as of 31 Mar 2024 | 225.00 | 0.01% |
| HighMark Wealth Management LLCas of 31 Mar 2024 | 127.00 | 0.01% |
| Qube Research & Technologies Ltd.as of 31 Dec 2023 | 92.00 | 0.01% |
| Citigroup Global Markets, Inc. (Investment Management)as of 31 Dec 2023 | 37.00 | 0.00% |
| Securities America Advisors, Inc.as of 31 Dec 2023 | 34.00 | 0.00% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Dec 2023 | 11.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
